PuigSRamos-AlonsoLRomeroAMMartnez-PastorMT
Zepbound (tirzepatide) is FDA-approved for weight loss and chronic weight management in obese individuals (body mass index, BMI 30 or above) and in overweight individuals (BMI 25 to 30) with at least one weight-related medical condition, such as high blood pressure, high cholesterol, or type 2 diabetes
A vast majority of individuals utilizing this physician-prescribed treatment consistently have the potential to attain their weight loss objectives within a three-month period
Why patients choose R+H Aesthetic Medicine for post-weight-loss tightening Patients who are navigating GLP-1 changes often share one fear: I do not want to gamble with my face. R+H Aesthetic Medicine is an award-winning, MD owned medical practice with deep injection and device expertise, built around safety, comfort, results, and luxury
You and your doctor will need to provide even more detailed evidence to argue why Humana's decision was incorrect
Our peptide regulation news article tracks the latest developments